193 related articles for article (PubMed ID: 24300917)
1. Clinical features of taxane neuropathy.
Kudlowitz D; Muggia F
Anticancer Drugs; 2014 May; 25(5):495-501. PubMed ID: 24300917
[TBL] [Abstract][Full Text] [Related]
2. Defining risks of taxane neuropathy: insights from randomized clinical trials.
Kudlowitz D; Muggia F
Clin Cancer Res; 2013 Sep; 19(17):4570-7. PubMed ID: 23817688
[TBL] [Abstract][Full Text] [Related]
3. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.
Rivera E; Cianfrocca M
Cancer Chemother Pharmacol; 2015 Apr; 75(4):659-70. PubMed ID: 25596818
[TBL] [Abstract][Full Text] [Related]
4. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.
Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL
Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586
[TBL] [Abstract][Full Text] [Related]
5. Taxanes in elderly breast cancer patients.
Wildiers H; Paridaens R
Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
[TBL] [Abstract][Full Text] [Related]
6. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
7. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
8. Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy.
Khan Z; Jung M; Crow M; Mohindra R; Maiya V; Kaminker JS; Hackos DH; Chandler GS; McCarthy MI; Bhangale T
Genome Med; 2023 Jun; 15(1):45. PubMed ID: 37344884
[TBL] [Abstract][Full Text] [Related]
9. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
10. Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.
Persohn E; Canta A; Schoepfer S; Traebert M; Mueller L; Gilardini A; Galbiati S; Nicolini G; Scuteri A; Lanzani F; Giussani G; Cavaletti G
Eur J Cancer; 2005 Jul; 41(10):1460-6. PubMed ID: 15913989
[TBL] [Abstract][Full Text] [Related]
11. Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.
Radaideh SM; Sledge GW
Breast Cancer Res Treat; 2008 Sep; 111(2):203-8. PubMed ID: 17990102
[TBL] [Abstract][Full Text] [Related]
12. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships.
Hertz DL
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):227-239. PubMed ID: 33401943
[No Abstract] [Full Text] [Related]
13. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
14. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.
Lavoie Smith EM; Cohen JA; Pett MA; Beck SL
Oncol Nurs Forum; 2011 Mar; 38(2):133-42. PubMed ID: 21356652
[TBL] [Abstract][Full Text] [Related]
15. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
17. Acute interstitial pneumopathy associated with docetaxel hypersensitivity.
Karacan O; Eyüboglu FO; Akçay S; Ozyilkan O
Onkologie; 2004 Dec; 27(6):563-5. PubMed ID: 15591716
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer.
Lycan TW; Hsu FC; Ahn CS; Thomas A; Walker FO; Sangueza OP; Shiozawa Y; Park SH; Peters CM; Romero-Sandoval EA; Melin SA; Sorscher S; Ansley K; Lesser GJ; Cartwright MS; Strowd RE
Muscle Nerve; 2020 May; 61(5):587-594. PubMed ID: 32052458
[TBL] [Abstract][Full Text] [Related]
19. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
20. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
